accumul
evid
suggest
human
cell
act
nonclass
cell
contribut
innat
adapt
immun
respons
infect
also
term
cell
exist
primat
human
repres
domin
circul
tcell
subset
primat
cell
cell
subset
capabl
recogn
microbi
phosphoantigen
sinc
nonhuman
primat
cell
resembl
human
counterpart
indepth
studi
undertaken
macaqu
understand
biolog
function
human
cell
articl
review
recent
progress
immun
biolog
cell
infect
accumul
evid
suggest
human
cell
function
nonclass
cell
contribut
innat
adapt
immun
respons
infect
also
term
cell
exist
primat
human
repres
major
circul
cell
subset
normal
constitut
total
peripher
blood
cell
sinc
macaqu
cell
resembl
human
counterpart
indepth
studi
undertaken
nonhuman
primat
understand
biolog
function
human
cell
articl
review
recent
progress
immun
respons
cell
infect
number
laboratori
includ
demonstr
cell
activ
vitro
certain
low
mw
foreignand
selfnonpeptid
phosphoryl
metabolit
isoprenoid
biosynthesi
eg
e
pyrophosph
hmbpp
isopentenyl
pyrophosph
ipp
isom
dimethylallyl
pyrophosph
dmapp
commonli
refer
phosphoantigen
microbi
phosphoantigen
hmbpp
produc
mep
pathway
isoprenoid
biosynthesi
number
bacteria
protozoa
infect
human
nonhuman
primat
hmbppproduc
microb
induc
major
expans
cell
typic
mycobacterium
bovi
bcg
mycobacterium
tuberculosi
produc
hmbpp
earli
infect
macaqu
mycobacteria
induc
remark
expans
cell
surprisingli
bcg
reinfect
bcg
infect
follow
tuberculosi
challeng
induc
rapid
recal
expans
adapt
immun
respons
macaqu
reoccurr
clonotyp
tcr
sequenc
cell
also
evid
rapid
recal
expans
suggest
memorylik
respons
new
studi
provid
addit
vivo
evid
indic
rapid
recal
expans
adapt
immun
respons
cell
also
induc
reinfect
macaqu
listeria
monocytogen
capabl
produc
hmbpp
ryan
et
al
intern
cell
confer
fact
increas
human
cell
cell
report
leprosi
granulomat
diseas
tubercul
mening
respect
see
review
exampl
infectiondriven
expans
human
cell
also
includ
salmonellosi
brucellosi
legionellosi
tularemia
brucellosi
legionellosi
malaria
toxoplasmosi
leishmaniasi
other
see
review
notion
human
cell
mount
adapt
immun
respons
infect
also
support
human
studi
howev
like
cell
cell
appear
depress
term
frequenc
effector
function
chronic
activ
tuberculosi
chronic
phase
aid
viru
infect
still
debat
whether
depress
cell
contribut
develop
activ
tuberculosi
result
immun
dysfunct
chronic
tuberculosi
extraordinari
expans
recal
expans
cell
infect
inde
argu
old
simpl
paradigm
human
cell
complet
function
innat
cell
notabl
human
cell
long
consid
innat
cell
due
lack
convinc
evid
indic
major
clonal
expans
adapt
featur
cell
nevertheless
emerg
evid
suggest
human
cell
innat
adapt
immun
featur
infect
like
infect
hmbppproduc
pathogen
drive
forc
adapt
immun
respons
cell
new
vivo
studi
suggest
hmbpp
infectiondriven
cytokin
need
clonal
expans
recal
expans
ryan
et
al
unpublish
data
help
explain
least
part
repeat
vivo
treatment
macaqu
phospholigand
induc
expans
cell
time
necessarili
stimul
greater
magnitud
recal
expans
time
treatment
find
deriv
small
phospholigand
treatment
rule
possibl
cell
contribut
adapt
immun
respons
infect
cell
exactli
resembl
cell
counterpart
mount
typic
recal
memori
respons
expos
simpl
treatment
compris
small
phospholigand
molecul
also
possibl
initi
treatment
phospholigand
alreadi
reach
maximum
activationexpans
potenti
cell
cell
cell
subsequ
treatment
abl
go
beyond
satur
point
due
host
selfcontrol
mechan
shuttingdown
overexpand
cell
clone
human
vitro
studi
also
implic
hmbpp
differ
infect
activ
function
cell
mycobacteriastimul
cell
hmbppactiv
cell
abl
suppress
tuberculosi
replic
primat
cell
subset
remain
cell
capabl
recogn
microbi
phosphoantigen
wherea
defin
microbi
antigen
recogn
cell
mice
speci
chemistri
phosphoantigen
abil
activ
cell
well
describ
molecular
mechan
hmbpp
interact
cell
remain
poorli
character
studi
done
date
focus
prenyl
pyrophosph
particularli
ipp
rare
microbi
phosphoantigen
hmbpp
earlier
experi
use
cell
activ
readout
demonstr
ipp
need
undergo
cellentri
process
phosphoantigen
activ
cell
requir
cellcel
contact
put
molecul
mhc
class
class
ii
appear
requir
present
ipp
immun
activ
cell
despit
decadelong
studi
howev
direct
evid
indic
human
macaqu
tcr
instead
human
macaqu
hybrid
directli
bind
hmbpp
hmbpp
complex
presum
develop
solubl
tetramer
tcr
would
provid
use
approach
explor
molecular
mechan
cell
interact
phosphoantigen
hmbpp
therefor
took
advantag
decadeslong
tcr
expertis
mhc
tetram
technolog
develop
highaffinitybind
solubl
tcr
tetram
demonstr
solubl
tcr
tetram
label
fluoresc
make
possibl
visual
apc
present
phosphoantigen
hmbpp
tcr
show
exogen
hmbpp
associ
apc
membran
appreci
affin
membraneassoci
hmbpp
readili
recogn
tcr
tetram
fig
fact
tcr
tetram
stabli
bind
hmbpp
present
membran
variou
apc
cell
line
human
nonhuman
primat
mous
rat
pig
find
suggest
tcr
one
import
element
dictat
specif
recognit
microbi
hmbpp
cell
tcr
tetram
also
bind
membraneassoci
hmbpp
primari
monocyt
b
cell
cell
suggest
variou
host
immun
cell
present
hmbpp
activ
cell
infect
hmbppproduc
pathogen
consist
endogen
phosphoantigen
produc
mycobacteriuminfect
dc
transport
present
membran
stabli
bound
tcr
tetram
particularli
signific
host
respons
infect
hmbppproduc
intracellular
pathogen
infect
apc
dc
macrophag
rapidli
present
hmbpp
tcr
earli
activ
expans
cell
interestingli
capabl
apc
present
hmbpp
recognit
tcr
diminish
proteas
treatment
apc
thu
studi
elucid
affin
hmbppapc
associ
confer
bind
tcr
put
apc
membran
molecul
present
hmbpp
appear
protein
proteinassoci
compon
exist
primat
apc
cell
rodent
apc
thu
tcr
tetramerbas
studi
enhanc
understand
molecular
aspect
interact
cell
apc
present
microbi
phosphoantigen
hmbpp
infect
sinc
tcr
dictat
specif
interact
microbi
phosphoantigen
hmbpp
would
interest
see
hmbppengag
tcr
molecul
event
drive
sequenti
activ
expans
cell
earli
infect
presum
molecular
imag
hmbpptrigger
tcr
respons
would
best
approach
elucid
tcr
molecul
respons
innov
combin
nearfield
optic
microscopi
nsom
fluoresc
quantum
dot
qd
nanotechnolog
nsomqd
develop
bestopticalresolut
nanoscal
molecular
imag
nm
system
visual
molecul
event
immun
cell
bestopticalresolut
molecular
imag
system
allow
us
show
nonstimul
tcr
molecul
rest
cell
distribut
individu
cell
surfac
mean
size
nm
fig
howev
hmbpp
pulsat
apc
engag
tcr
rapidli
induc
format
nm
tcr
nanoclust
tcr
molecul
event
coincid
transloc
membran
signal
transduct
activ
data
shown
surprisingli
tcr
nanoclust
sustain
membran
vivo
clonal
expans
cell
treatment
mycobacteri
infect
tcr
nanoclust
array
form
nanodomain
microdomain
membran
clonallyexpand
cell
fig
interestingli
expand
cell
bear
tcr
nanoclust
nanodomain
abl
rerecogn
phosphoantigen
exert
better
effector
function
contrast
nonspecif
stimul
induc
tcr
nanoclust
nanodomain
format
nanoscal
novel
find
suggest
tcr
play
fundament
role
recognit
hmbpp
subsequ
clonal
activ
expans
cell
infect
hmbppproduc
pathogen
cytokin
produc
infect
may
contribut
develop
adapt
immun
respons
cell
infect
hmbppproduc
pathogen
scenario
support
studi
us
other
found
tuberculosi
bcg
infect
macaqu
induc
major
expans
cell
coincid
express
variant
mrna
encod
protein
compris
ntermin
amino
acid
aa
ident
uniqu
ctermin
aa
includ
signalingrel
prolinerich
motif
express
purifi
test
possibl
variant
cytokin
contribut
major
expans
cell
purifi
induc
appar
expans
phosphoantigen
hmbppspecif
cell
doseand
timedepend
manner
uniqu
ctermin
aa
bear
prolinerich
motif
pppcpp
appear
confer
abil
expand
cell
sinc
simultan
produc
subtl
effect
cell
moreov
seem
util
receptor
signal
activ
expans
cell
block
mab
mab
surprisingli
cell
hmbpp
stimul
appear
heterolog
effector
cell
capabl
produc
thu
mycobacteri
infect
macaqu
induc
variant
mrna
encod
function
growth
factor
promot
expans
hmbppspecif
effector
cell
presum
cytokin
may
also
exert
similar
effect
facilit
major
expans
cell
mycobacteri
infect
fact
report
also
stimul
mark
expans
hmbppspecif
cell
new
studi
also
demonstr
contribut
signific
expans
cell
mycobacteri
infect
ryan
et
al
intern
cell
confer
human
vitro
studi
also
show
could
help
develop
antimicrobi
function
cell
tuberculosi
infect
sinc
hmbpp
alon
cytokin
alon
abl
induc
major
expans
cell
cytokin
may
function
second
third
signal
sustain
hmbpptcrmediat
activ
clonal
expans
infect
long
postul
cell
may
bridg
innat
adapt
immun
respons
infect
presum
due
enrich
distribut
cell
mucosa
hypothesi
well
test
mice
sinc
mous
cell
recogn
phosphoantigen
hmbpp
microbi
antigen
address
treat
macaqu
hmbpp
compound
plu
regimen
investig
activationexpans
cell
impact
immun
respons
infect
first
defin
util
immun
kinet
singledos
hmbpp
plu
treatment
regimen
macaqu
found
regimen
could
expand
macaqu
cell
baselin
cell
pool
without
detect
side
effect
hmbppactiv
cell
produc
cytokin
readili
traffick
lung
oral
gut
mucosa
sustain
pulmonari
accumul
month
investig
whether
welldefin
therapeut
regimen
could
overcom
hivmedi
immun
suppress
massiv
expand
polyfunct
cell
whether
activationexpans
could
impact
aid
pathogenesi
simian
hiv
shiv
infect
macaqu
coadministr
chronic
phase
shiv
infect
induc
massiv
activationexpans
cell
cotreat
chronic
infect
exacerb
diseas
importantli
could
confer
immunolog
benefit
surprisingli
although
viral
antigen
load
decreas
upon
cotreat
chronic
shiv
infect
hmbpp
activ
cell
boost
hiv
envspecif
ab
titer
increas
ab
sustain
day
immedi
preced
increas
product
peak
expans
cell
display
memori
phenotyp
well
shortterm
increas
effector
function
cell
cell
produc
antimicrobi
cytokin
signific
find
twofold
cellbas
intervent
potenti
use
combat
neoplasm
hmbppproduc
opportunist
pathogen
chronic
hivinfect
individu
hmbppactiv
cell
may
function
adjuv
facilit
b
cell
produc
ab
enhanc
cell
produc
antimicrobi
cytokin
infect
fact
observ
macaqu
consist
find
vitro
human
studi
shown
activ
human
cell
stimul
dc
matur
hmbppdepend
crosstalk
monocyt
human
cell
drive
fast
inflammatori
cytokin
respons
monocyt
differenti
dc
facilit
develop
helper
cell
presenc
addit
microbi
stimul
activ
human
cell
appear
function
apc
vitro
present
peptid
antigen
cell
cell
also
shown
improv
b
cell
abil
produc
antibodi
vitro
studi
need
prove
tent
concept
effector
cell
may
potenti
enhanc
agspecif
ab
respons
cell
respons
infect
activ
cell
produc
cytokin
mani
cytokin
therefor
may
influenc
effector
cell
host
respons
infect
assess
possibl
sought
determin
whether
cell
could
direct
impact
cell
popul
vivo
infect
vaccin
studi
focus
two
aspect
interplay
regulatori
cell
treg
hmbppactiv
effector
cell
mycobacteri
infect
celldriven
immun
regul
potenti
inflammatori
cell
tuberculosi
treg
cell
control
immun
respons
selfand
foreignantigen
play
major
role
maintain
balanc
immun
toler
treg
benefici
control
autoimmun
allograft
reject
hypersensit
overrespons
infect
may
lead
suppress
host
antimicrobi
immun
develop
use
model
system
may
help
identifi
potenti
mutual
regulatori
effect
treg
immun
cell
element
interestingli
recent
studi
shown
human
recombin
administr
lead
increas
frequenc
circul
regulatori
cell
cancer
patient
other
also
shown
plu
phospholigand
treatment
induc
remark
expans
cell
nonhuman
primat
therefor
took
advantag
vivo
model
system
assess
potenti
interplay
mutual
regul
cell
treg
earli
mycobacteri
infect
nonhuman
primat
shortterm
treatment
regimen
induc
mark
expans
cell
subsequ
suppress
mycobacteriumdriven
increas
cell
acut
bcginfect
macaqu
surprisingli
activ
cell
ad
phosphoantigen
picostim
similar
hmbpp
treatment
regimen
appar
downregul
expans
cell
downregul
expans
treg
coincid
sustain
increas
number
cell
day
treatment
superimpos
bcg
infect
consist
vitro
activ
cell
pbmc
downregul
expans
cell
hmbppmediat
antagon
effect
appear
requir
apc
monocyt
lymphocyt
sinc
activ
cell
alon
inhibit
effect
cell
cultur
without
apc
cell
pbmc
sought
determin
whether
cytokin
produc
phosphoantigenactiv
cell
contribut
downregul
prolifer
treg
set
cytokineneutr
experi
prolifer
assay
use
neutral
antibodi
hmbpp
phosphoantigen
stimul
could
upregul
mani
gene
includ
encod
cytokin
wang
et
al
data
shown
surprisingli
neutral
antibodi
affect
hmbppmediat
downregul
treg
neutral
antibodi
significantli
reduc
abil
hmbppactiv
cell
antagon
treg
expans
suggest
network
contribut
cell
antagon
effect
furthermor
activ
cell
picostim
treatment
appear
revers
tregdriven
suppress
immun
respons
phosphoantigenspecif
cell
ppdspecif
cell
thu
phosphoantigenactiv
cell
antagon
expans
treg
subsequ
suppress
antimicrobi
cell
respons
mycobacteri
infect
find
treatment
macaqu
context
mycobacteri
infect
provid
first
evid
suggest
certain
cell
subset
immun
system
antagon
suppress
agspecif
cell
respons
infect
given
possibl
overreact
effector
cell
may
contribut
inflamm
tissu
damag
infect
sought
determin
hmbppactiv
cell
regul
potenti
inflammatori
cell
end
focus
cell
interplay
cell
infect
shown
play
role
inflamm
autoimmun
first
demonstr
nonhuman
primat
model
tuberculosi
infect
result
appar
increas
number
cell
capabl
produc
de
novo
without
vitro
ag
stimul
drive
distribut
cell
dramat
lung
blood
lymphoid
tissu
consist
cell
visual
situ
lung
tuberculosi
tb
granuloma
confoc
microscopi
immunohistochemistri
indic
matur
cell
present
tb
granuloma
surprisingli
hmbpp
activ
cell
downregul
capabl
cell
produc
de
novo
lymphocyt
blood
lungbal
fluid
spleen
lymph
node
upregul
effector
cell
hmbpp
stimul
coincid
downregul
capac
cell
produc
de
novo
importantli
neutral
ab
treatment
revers
hmbppmediat
downregul
effect
cell
suggest
celldriven
function
mechan
underli
hmbppmediat
downregul
capabl
cell
produc
novel
find
rais
possibl
ultim
investig
function
cell
target
cell
balanc
potenti
hyperactiv
cell
sever
tb
studi
demonstr
one
remark
immun
featur
hmbppspecif
cell
capabl
traffic
lung
mucos
surfac
activ
expand
howev
possibl
effector
cell
confer
protect
pulmonari
infecti
diseas
test
sinc
reproduc
show
hmbpp
plu
treatment
induc
prolong
accumul
effector
cell
lung
investig
whether
expand
cell
mediat
protect
acut
fatal
pneumon
plagu
macaqu
model
inhal
yersinia
pesti
infect
delay
administr
inhal
yersinia
pesti
infect
overcam
acut
infect
induc
mark
expans
cell
expand
cell
fail
control
extracellular
plagu
bacteri
replicationinfect
led
extrathorac
dissemin
septicemia
fatal
shock
appear
understand
sinc
extracellular
bacteri
infect
would
usual
control
neutral
antibodi
effector
cell
surprisingli
despit
absenc
infect
control
expans
cell
treatment
led
attenu
inhal
plagu
lesion
lung
consist
hmbppactiv
cell
accumul
local
pulmonari
interstiti
surround
small
blood
vessel
airway
mucosa
lung
tissu
mild
plagu
lesion
infiltr
cell
produc
homeostat
mediat
tissu
damag
contrast
control
macaqu
treat
glucos
plu
glucos
alon
exhibit
sever
hemorrhag
necrosi
lung
lobe
cell
detect
lung
tissu
find
consist
paradigm
circul
cell
traffic
lung
homeostat
protect
tissu
damag
infect
find
inde
provid
first
vivo
evid
human
primat
indic
cell
contribut
antimicrobi
immun
conclus
much
progress
made
past
year
infect
phosphoantigenproduc
microb
drive
adapt
immun
respons
cell
human
nonhuman
primat
tcr
appear
respons
recognit
phosphoantigen
hmbpp
present
apc
subsequ
clonal
activ
expans
cell
infect
cytokin
produc
infect
play
critic
role
mount
adapt
immun
respons
hmbppspecif
cell
preliminari
data
suggest
effector
cell
may
potenti
enhanc
agspecif
ab
respons
cell
respons
infect
addit
effector
cell
may
function
immun
regul
antagon
cell
influenc
effector
cell
infect
importantli
effector
cell
readili
traffic
lung
contribut
host
resist
pathogeninduc
lung
damag
acut
pulmonari
infect
flow
cytometri
histogram
show
fitclabel
tcr
tetram
bound
membraneassoci
hmbpp
present
macaqu
primari
b
cell
cell
monocyt
larg
proport
cell
popul
stain
posit
tcr
tetram
stain
seen
two
control
cell
puls
hmbpp
directli
incub
fitclabel
tcr
tetram
hmbpp
cell
puls
hmbpp
incub
fitclabel
tcr
tetram
control
